On top of the normal Monthly/Annual subscription options, readers can gain lifetime membership to PL+ and PL Pro at the cost of ~4 years: We are limiting the number of lifetime subscriptions at this ...
Enanta Pharmaceuticals Inc. has patented compounds acting as nonstructural protein 3 (nsp3, PL-pro; SARS-CoV-2) inhibitors reported to be useful for the treatment of asthma, SARS-CoV-2 infection ...
The State University of New Jersey (Rutgers) has synthesized non-structural protein 3 (nsp3; PL-pro) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of viral infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results